Concepts (293)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 19 | 2019 | 409 | 2.900 |
Why?
|
| Mammography | 12 | 2017 | 48 | 2.190 |
Why?
|
| Racism | 4 | 2022 | 33 | 1.860 |
Why?
|
| Kidney Failure, Chronic | 16 | 2021 | 165 | 1.840 |
Why?
|
| Early Detection of Cancer | 5 | 2018 | 105 | 1.740 |
Why?
|
| Healthcare Disparities | 7 | 2023 | 89 | 1.710 |
Why?
|
| Health Services Accessibility | 13 | 2021 | 111 | 1.600 |
Why?
|
| Health Status Disparities | 5 | 2020 | 78 | 1.540 |
Why?
|
| Renal Replacement Therapy | 9 | 2011 | 23 | 1.450 |
Why?
|
| Registries | 14 | 2010 | 188 | 1.440 |
Why?
|
| Kidney Transplantation | 8 | 2021 | 133 | 1.390 |
Why?
|
| Medically Uninsured | 2 | 2021 | 13 | 1.230 |
Why?
|
| Physicians | 2 | 2022 | 124 | 1.090 |
Why?
|
| Humans | 74 | 2023 | 28435 | 0.940 |
Why?
|
| Primary Health Care | 3 | 2021 | 98 | 0.880 |
Why?
|
| Practice Patterns, Physicians' | 5 | 2018 | 122 | 0.880 |
Why?
|
| Health Facilities | 1 | 2023 | 22 | 0.820 |
Why?
|
| Health Equity | 1 | 2023 | 18 | 0.810 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 137 | 0.800 |
Why?
|
| Chicago | 23 | 2019 | 947 | 0.790 |
Why?
|
| Human Rights | 1 | 2022 | 3 | 0.780 |
Why?
|
| Middle Aged | 41 | 2021 | 9270 | 0.780 |
Why?
|
| Female | 54 | 2021 | 15728 | 0.770 |
Why?
|
| Referral and Consultation | 3 | 2021 | 91 | 0.750 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 157 | 0.740 |
Why?
|
| Ambulatory Care Facilities | 1 | 2021 | 40 | 0.730 |
Why?
|
| Community Health Services | 1 | 2021 | 35 | 0.720 |
Why?
|
| Dyslipidemias | 2 | 2018 | 18 | 0.720 |
Why?
|
| Health Personnel | 1 | 2022 | 107 | 0.720 |
Why?
|
| Adult | 36 | 2021 | 8107 | 0.690 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 61 | 0.680 |
Why?
|
| Emergency Service, Hospital | 4 | 2022 | 259 | 0.660 |
Why?
|
| Hospitalization | 2 | 2022 | 323 | 0.650 |
Why?
|
| Mass Screening | 10 | 2017 | 183 | 0.650 |
Why?
|
| Cardiovascular Diseases | 4 | 2018 | 372 | 0.650 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 7 | 0.640 |
Why?
|
| Carcinoma, Ductal | 1 | 2019 | 5 | 0.640 |
Why?
|
| Renal Dialysis | 9 | 2021 | 123 | 0.620 |
Why?
|
| Socioeconomic Factors | 10 | 2020 | 310 | 0.620 |
Why?
|
| Cholesterol, LDL | 2 | 2018 | 32 | 0.620 |
Why?
|
| Social Determinants of Health | 1 | 2018 | 33 | 0.590 |
Why?
|
| Violence | 1 | 2018 | 42 | 0.590 |
Why?
|
| Practice Guidelines as Topic | 7 | 2018 | 320 | 0.590 |
Why?
|
| Aged | 30 | 2021 | 9278 | 0.570 |
Why?
|
| Survival Rate | 6 | 2010 | 356 | 0.560 |
Why?
|
| Mortality | 5 | 2018 | 90 | 0.540 |
Why?
|
| Multicenter Studies as Topic | 3 | 2010 | 51 | 0.510 |
Why?
|
| Undocumented Immigrants | 1 | 2015 | 2 | 0.490 |
Why?
|
| Residence Characteristics | 5 | 2019 | 215 | 0.490 |
Why?
|
| Health Policy | 2 | 2015 | 50 | 0.490 |
Why?
|
| Value of Life | 1 | 2015 | 1 | 0.480 |
Why?
|
| Insurance Coverage | 1 | 2015 | 16 | 0.480 |
Why?
|
| United Kingdom | 11 | 2011 | 51 | 0.480 |
Why?
|
| Pregnancy Outcome | 3 | 2014 | 18 | 0.470 |
Why?
|
| Hospitals | 4 | 2022 | 156 | 0.420 |
Why?
|
| Male | 30 | 2021 | 15292 | 0.420 |
Why?
|
| Young Adult | 12 | 2021 | 2070 | 0.420 |
Why?
|
| Waiting Lists | 2 | 2010 | 17 | 0.410 |
Why?
|
| Outpatient Clinics, Hospital | 4 | 2002 | 15 | 0.410 |
Why?
|
| Community Health Planning | 2 | 2009 | 21 | 0.400 |
Why?
|
| Cause of Death | 3 | 2010 | 64 | 0.400 |
Why?
|
| United States | 10 | 2021 | 2200 | 0.400 |
Why?
|
| Tissue Donors | 2 | 2010 | 84 | 0.390 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 625 | 0.380 |
Why?
|
| Peritoneal Dialysis | 2 | 2011 | 25 | 0.380 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 933 | 0.370 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 821 | 0.370 |
Why?
|
| Retrospective Studies | 11 | 2021 | 3612 | 0.360 |
Why?
|
| Hemoglobins | 4 | 2009 | 78 | 0.360 |
Why?
|
| National Health Programs | 2 | 2010 | 3 | 0.350 |
Why?
|
| Cesarean Section | 4 | 2014 | 30 | 0.350 |
Why?
|
| Adolescent | 9 | 2021 | 2309 | 0.350 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 14 | 0.340 |
Why?
|
| Risk Assessment | 7 | 2018 | 677 | 0.330 |
Why?
|
| Community Participation | 1 | 2009 | 18 | 0.330 |
Why?
|
| Risk Factors | 10 | 2018 | 2408 | 0.310 |
Why?
|
| ErbB Receptors | 1 | 2009 | 54 | 0.310 |
Why?
|
| Breech Presentation | 1 | 2008 | 3 | 0.310 |
Why?
|
| Version, Fetal | 1 | 2008 | 3 | 0.310 |
Why?
|
| Medical Audit | 1 | 2008 | 6 | 0.310 |
Why?
|
| Aged, 80 and over | 11 | 2018 | 4857 | 0.300 |
Why?
|
| Pregnancy | 8 | 2020 | 341 | 0.300 |
Why?
|
| Smoking | 2 | 2005 | 177 | 0.280 |
Why?
|
| Hospitals, Public | 6 | 2002 | 25 | 0.280 |
Why?
|
| Incidence | 7 | 2019 | 773 | 0.280 |
Why?
|
| Diabetes Mellitus | 3 | 2005 | 137 | 0.270 |
Why?
|
| Annual Reports as Topic | 3 | 2010 | 3 | 0.260 |
Why?
|
| Guideline Adherence | 3 | 2018 | 65 | 0.250 |
Why?
|
| Intubation | 1 | 2005 | 6 | 0.250 |
Why?
|
| Heroin Dependence | 1 | 2005 | 9 | 0.250 |
Why?
|
| Cocaine-Related Disorders | 1 | 2005 | 13 | 0.250 |
Why?
|
| Public Health | 2 | 2017 | 70 | 0.250 |
Why?
|
| Extraction, Obstetrical | 2 | 1995 | 2 | 0.250 |
Why?
|
| Tobacco Use Disorder | 1 | 2005 | 18 | 0.240 |
Why?
|
| Smoking Cessation | 1 | 2005 | 48 | 0.230 |
Why?
|
| Geographic Information Systems | 1 | 2004 | 4 | 0.230 |
Why?
|
| Diabetes, Gestational | 2 | 2014 | 9 | 0.230 |
Why?
|
| Time Factors | 6 | 2018 | 1491 | 0.220 |
Why?
|
| Age Factors | 6 | 2018 | 781 | 0.220 |
Why?
|
| Treatment Outcome | 5 | 2018 | 3616 | 0.220 |
Why?
|
| New Zealand | 6 | 2019 | 11 | 0.220 |
Why?
|
| Health Status Indicators | 1 | 2004 | 75 | 0.220 |
Why?
|
| Cities | 3 | 2018 | 17 | 0.210 |
Why?
|
| Poverty | 5 | 2010 | 100 | 0.210 |
Why?
|
| Asthma | 1 | 2005 | 162 | 0.210 |
Why?
|
| Commerce | 1 | 2023 | 12 | 0.210 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 1994 | 35 | 0.210 |
Why?
|
| Patient Transfer | 2 | 1996 | 23 | 0.200 |
Why?
|
| Uncompensated Care | 1 | 2002 | 1 | 0.200 |
Why?
|
| Databases, Factual | 3 | 2019 | 358 | 0.200 |
Why?
|
| Delivery, Obstetric | 2 | 2019 | 12 | 0.190 |
Why?
|
| Morbidity | 2 | 2001 | 58 | 0.190 |
Why?
|
| Health Priorities | 1 | 2001 | 4 | 0.190 |
Why?
|
| Public Health Administration | 1 | 2001 | 9 | 0.190 |
Why?
|
| Patient Compliance | 3 | 2018 | 164 | 0.190 |
Why?
|
| Social Class | 3 | 2010 | 67 | 0.190 |
Why?
|
| Aftercare | 1 | 2021 | 26 | 0.180 |
Why?
|
| Health Surveys | 3 | 2007 | 88 | 0.180 |
Why?
|
| Dystocia | 1 | 2020 | 1 | 0.170 |
Why?
|
| Research Design | 2 | 2020 | 207 | 0.170 |
Why?
|
| Neoplasms | 2 | 2017 | 239 | 0.170 |
Why?
|
| Income | 2 | 2005 | 78 | 0.160 |
Why?
|
| Cholesterol | 2 | 2018 | 64 | 0.160 |
Why?
|
| Sociology, Medical | 1 | 2019 | 3 | 0.160 |
Why?
|
| Hospitals, Urban | 2 | 1998 | 32 | 0.160 |
Why?
|
| Mortality, Premature | 1 | 2018 | 6 | 0.150 |
Why?
|
| Survival Analysis | 2 | 2009 | 267 | 0.150 |
Why?
|
| Illinois | 4 | 2015 | 246 | 0.150 |
Why?
|
| Infant, Low Birth Weight | 1 | 2018 | 18 | 0.150 |
Why?
|
| Global Health | 1 | 2018 | 42 | 0.150 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 18 | 0.150 |
Why?
|
| Quality of Health Care | 4 | 2020 | 126 | 0.150 |
Why?
|
| General Practice | 1 | 2018 | 2 | 0.150 |
Why?
|
| Germany | 1 | 2017 | 6 | 0.150 |
Why?
|
| Biomarkers | 2 | 2018 | 596 | 0.150 |
Why?
|
| Infant, Newborn | 5 | 2019 | 655 | 0.140 |
Why?
|
| Women's Health | 2 | 2017 | 176 | 0.140 |
Why?
|
| Medical Overuse | 1 | 2017 | 8 | 0.140 |
Why?
|
| Comorbidity | 2 | 2017 | 500 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2017 | 102 | 0.140 |
Why?
|
| Prevalence | 5 | 2014 | 468 | 0.140 |
Why?
|
| False Negative Reactions | 1 | 2016 | 14 | 0.140 |
Why?
|
| Health Education | 3 | 1994 | 53 | 0.130 |
Why?
|
| Quality Control | 1 | 2016 | 32 | 0.130 |
Why?
|
| Facility Regulation and Control | 1 | 1996 | 1 | 0.130 |
Why?
|
| Urban Health | 3 | 2004 | 22 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 196 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 518 | 0.130 |
Why?
|
| Epidemiologic Methods | 2 | 2015 | 16 | 0.130 |
Why?
|
| Observer Variation | 1 | 2016 | 102 | 0.130 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 38 | 0.130 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 371 | 0.130 |
Why?
|
| Emergency Medical Services | 1 | 1996 | 29 | 0.130 |
Why?
|
| Urban Population | 5 | 2005 | 156 | 0.130 |
Why?
|
| Wales | 3 | 2010 | 4 | 0.130 |
Why?
|
| England | 3 | 2010 | 12 | 0.120 |
Why?
|
| Civil Defense | 1 | 2015 | 5 | 0.120 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 7 | 0.120 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 38 | 0.120 |
Why?
|
| Financing, Government | 1 | 2015 | 10 | 0.120 |
Why?
|
| Reimbursement Mechanisms | 1 | 2015 | 12 | 0.120 |
Why?
|
| Patient Safety | 1 | 2016 | 54 | 0.120 |
Why?
|
| Hospitals, Maternity | 1 | 1995 | 3 | 0.120 |
Why?
|
| Stereotyping | 1 | 2015 | 18 | 0.120 |
Why?
|
| Schools, Medical | 1 | 2015 | 27 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 1998 | 328 | 0.120 |
Why?
|
| Birth Weight | 1 | 2014 | 46 | 0.120 |
Why?
|
| Cohort Studies | 6 | 2019 | 1926 | 0.110 |
Why?
|
| Faculty, Medical | 1 | 2015 | 44 | 0.110 |
Why?
|
| HIV Seroprevalence | 1 | 1994 | 3 | 0.110 |
Why?
|
| Syphilis | 1 | 1994 | 3 | 0.110 |
Why?
|
| Students, Medical | 1 | 2015 | 55 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 737 | 0.110 |
Why?
|
| Community Health Nursing | 1 | 1994 | 9 | 0.110 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1994 | 17 | 0.110 |
Why?
|
| Postpartum Period | 1 | 1993 | 24 | 0.110 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 91 | 0.100 |
Why?
|
| Prognosis | 2 | 2012 | 825 | 0.090 |
Why?
|
| Hemodialysis, Home | 1 | 2011 | 1 | 0.090 |
Why?
|
| Tetanus | 1 | 2011 | 1 | 0.090 |
Why?
|
| Disasters | 1 | 2011 | 2 | 0.090 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2011 | 13 | 0.090 |
Why?
|
| Developing Countries | 1 | 2011 | 14 | 0.090 |
Why?
|
| Europe | 4 | 2010 | 66 | 0.090 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2010 | 20 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2010 | 84 | 0.090 |
Why?
|
| Hemodialysis Units, Hospital | 1 | 2009 | 1 | 0.080 |
Why?
|
| Advisory Committees | 1 | 2009 | 25 | 0.080 |
Why?
|
| Living Donors | 1 | 2009 | 17 | 0.080 |
Why?
|
| Health Services Research | 3 | 2002 | 42 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2009 | 1809 | 0.080 |
Why?
|
| HIV Infections | 1 | 1994 | 488 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2009 | 81 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2009 | 268 | 0.080 |
Why?
|
| Counseling | 1 | 2008 | 45 | 0.080 |
Why?
|
| Logistic Models | 1 | 2009 | 396 | 0.070 |
Why?
|
| Interviews as Topic | 2 | 2002 | 138 | 0.070 |
Why?
|
| Mexico | 1 | 2007 | 18 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 492 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2007 | 67 | 0.070 |
Why?
|
| Patient Selection | 1 | 1987 | 206 | 0.060 |
Why?
|
| Parathyroid Hormone | 3 | 2010 | 25 | 0.060 |
Why?
|
| Unemployment | 1 | 2005 | 2 | 0.060 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2004 | 2 | 0.060 |
Why?
|
| Reoperation | 1 | 2009 | 917 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 16 | 0.060 |
Why?
|
| Chest Pain | 1 | 2004 | 19 | 0.060 |
Why?
|
| Acute Disease | 1 | 2005 | 208 | 0.060 |
Why?
|
| Infant | 2 | 2009 | 588 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2009 | 689 | 0.060 |
Why?
|
| Glucose Tolerance Test | 2 | 2014 | 14 | 0.060 |
Why?
|
| Attitude to Health | 3 | 2011 | 105 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 1859 | 0.060 |
Why?
|
| Educational Status | 1 | 2005 | 300 | 0.050 |
Why?
|
| Lung | 1 | 2004 | 170 | 0.050 |
Why?
|
| Disease Outbreaks | 2 | 2011 | 82 | 0.050 |
Why?
|
| Critical Care | 1 | 2005 | 199 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 2005 | 306 | 0.050 |
Why?
|
| Disease Progression | 1 | 2005 | 718 | 0.050 |
Why?
|
| Child | 2 | 2009 | 1421 | 0.050 |
Why?
|
| Policy | 1 | 2021 | 11 | 0.050 |
Why?
|
| Poverty Areas | 1 | 2001 | 10 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 1550 | 0.050 |
Why?
|
| Health Care Surveys | 2 | 1998 | 66 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2009 | 266 | 0.050 |
Why?
|
| Medicare | 1 | 2021 | 121 | 0.040 |
Why?
|
| Phosphates | 2 | 2010 | 22 | 0.040 |
Why?
|
| Axilla | 1 | 2019 | 13 | 0.040 |
Why?
|
| Traction | 1 | 2019 | 33 | 0.040 |
Why?
|
| Life Expectancy | 1 | 2018 | 28 | 0.040 |
Why?
|
| Ontario | 1 | 2018 | 15 | 0.040 |
Why?
|
| Medical Indigency | 1 | 1998 | 1 | 0.040 |
Why?
|
| North America | 1 | 2018 | 43 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 81 | 0.040 |
Why?
|
| Italy | 1 | 2018 | 11 | 0.040 |
Why?
|
| Hospital Charges | 1 | 1998 | 16 | 0.040 |
Why?
|
| Geography | 1 | 2018 | 18 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2018 | 110 | 0.040 |
Why?
|
| Calcium | 2 | 2010 | 381 | 0.030 |
Why?
|
| Community Health Centers | 3 | 1993 | 13 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 594 | 0.030 |
Why?
|
| Pacific Islands | 1 | 1995 | 2 | 0.030 |
Why?
|
| Analgesia, Obstetrical | 1 | 1995 | 26 | 0.030 |
Why?
|
| Analgesia, Epidural | 1 | 1995 | 54 | 0.030 |
Why?
|
| Organizational Policy | 1 | 1995 | 17 | 0.030 |
Why?
|
| Fetal Macrosomia | 1 | 2014 | 1 | 0.030 |
Why?
|
| Labor, Induced | 1 | 2014 | 3 | 0.030 |
Why?
|
| Fasting | 1 | 2014 | 22 | 0.030 |
Why?
|
| Health Resources | 1 | 2014 | 23 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 58 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 1994 | 18 | 0.030 |
Why?
|
| Fetal Death | 1 | 1993 | 5 | 0.030 |
Why?
|
| Medical Records | 1 | 1993 | 34 | 0.030 |
Why?
|
| Program Evaluation | 1 | 1994 | 137 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1994 | 185 | 0.020 |
Why?
|
| New York City | 1 | 2011 | 15 | 0.020 |
Why?
|
| Clostridium tetani | 1 | 2011 | 1 | 0.020 |
Why?
|
| Tetanus Toxoid | 1 | 2011 | 1 | 0.020 |
Why?
|
| Endemic Diseases | 1 | 2011 | 7 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2011 | 14 | 0.020 |
Why?
|
| Metronidazole | 1 | 2011 | 5 | 0.020 |
Why?
|
| Wounds, Penetrating | 1 | 2011 | 7 | 0.020 |
Why?
|
| Vaccination | 1 | 2011 | 31 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 36 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2009 | 22 | 0.020 |
Why?
|
| Asia | 1 | 2009 | 10 | 0.020 |
Why?
|
| Bicarbonates | 1 | 2009 | 3 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 352 | 0.020 |
Why?
|
| Ferritins | 1 | 2009 | 9 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 205 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2009 | 24 | 0.020 |
Why?
|
| Vaginal Smears | 3 | 1993 | 11 | 0.020 |
Why?
|
| Papanicolaou Test | 3 | 1993 | 9 | 0.020 |
Why?
|
| Ethics, Institutional | 1 | 1987 | 1 | 0.020 |
Why?
|
| Insurance, Hospitalization | 1 | 1987 | 2 | 0.020 |
Why?
|
| Government Regulation | 1 | 1987 | 3 | 0.020 |
Why?
|
| Federal Government | 1 | 1987 | 4 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 1987 | 27 | 0.020 |
Why?
|
| Transfer Agreement | 1 | 1986 | 1 | 0.020 |
Why?
|
| Patient Admission | 1 | 1986 | 26 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2004 | 12 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1384 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2004 | 28 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2005 | 147 | 0.010 |
Why?
|
| Physical Examination | 2 | 1993 | 118 | 0.010 |
Why?
|
| Health Services | 1 | 1998 | 8 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 269 | 0.010 |
Why?
|
| Computers | 1 | 1976 | 20 | 0.010 |
Why?
|
| Appointments and Schedules | 1 | 1993 | 14 | 0.010 |
Why?
|
| Data Collection | 1 | 1993 | 98 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1986 | 9 | 0.000 |
Why?
|
| Time | 1 | 1986 | 15 | 0.000 |
Why?
|
| Demography | 1 | 1986 | 73 | 0.000 |
Why?
|